Franklin Resources’s Emergent Biosolutions EBS Stock Holding History

Franklin Resources’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Buy	166,843 +4,900	+3%	+$41K	﹤0.01%	2140
2026 Q1	$1.34M	Buy	161,943 +82,998	+105%	+$860K	﹤0.01%	2071
2025 Q4	$976K	Buy	78,945 +1,764	+2%	+$18.9K	﹤0.01%	2092
2025 Q3	$681K	Buy	+77,181	New	+$600K	﹤0.01%	2292
2021 Q4	–	Sell	-4,227	Closed	-$212K	–	2493
2021 Q3	$212K	Sell	4,227 -73,852	-95%	-$4.47M	﹤0.01%	2220
2021 Q2	$4.92M	Sell	78,079 -364,883	-82%	-$23.4M	﹤0.01%	1142
2021 Q1	$41.2M	Buy	442,962 +2,845	+0.6%	+$291K	0.02%	670
2020 Q4	$39.4M	Buy	440,117 +32,561	+8%	+$2.99M	0.02%	655
2020 Q3	$42.1M	Buy	407,556 +467	+0.1%	+$50.3K	0.02%	597
2020 Q2	$38.3M	Sell	407,089 -884	-0.2%	-$65.9K	0.02%	598
2020 Q1	$23.6M	Sell	407,973 -21,558	-5%	-$1.24M	0.02%	636
2019 Q4	$23.2M	Sell	429,531 -695	-0.2%	-$37.7K	0.01%	726
2019 Q3	$22.5M	Buy	430,226 +40,692	+10%	+$1.9M	0.01%	715
2019 Q2	$18.8M	Buy	389,534 +182,197	+88%	+$8.73M	0.01%	760
2019 Q1	$10.5M	Buy	+207,337	New	+$12.2M	0.01%	864

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Franklin Resources's EBS Position: Q2 2026 in Review

Franklin Resources increased its Emergent Biosolutions (EBS) stake by 3% in Q2 2026, buying an estimated $41K and bringing the position to 166,843 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2140.

Franklin Resources first reported a position in EBS in Q1 2019 and has held it in 15 quarters since. The position peaked at $42.1M in Q3 2020. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Franklin Resources held 166,843 shares of Emergent Biosolutions worth $1.4M as of Q2 2026.
Franklin Resources bought 4,900 Emergent Biosolutions shares in Q2 2026, an estimated $41K.
Emergent Biosolutions made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2140 holding.
Franklin Resources first reported a position in Emergent Biosolutions in Q1 2019 and has held it in 15 quarters since.
Franklin Resources's Emergent Biosolutions position peaked at $42.1M in Q3 2020.
195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.